Skip to main content
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. — Investor Relations & Filings

Ticker · BEAM ISIN · US07373V1052 US Manufacturing
Open in API
Filings indexed 457 across all filing types
Latest filing 2019-08-26 Regulatory Filings
Country US United States of America
Listing US BEAM

About Beam Therapeutics Inc.

https://beamtx.com/

Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines using its proprietary base editing technology. This approach is designed to make precise, single-letter edits to the genome without causing double-stranded breaks in the DNA, aiming to overcome the limitations of traditional gene editing methods. The company's pipeline focuses on creating potential life-long cures for genetic disorders, including sickle cell disease, beta-thalassemia, and alpha-1 antitrypsin deficiency. Beam Therapeutics is also advancing a suite of delivery technologies, such as electroporation, nonviral, and viral modalities, to deliver its base editors to target cells.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2019
Regulatory Filings
2019-08-26 English
Regulatory Filings 2019
Regulatory Filings
2019-08-23 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC) for Beam Therapeutics Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings (IPOs) or other securities offerings. The text includes details about the offering, underwriting, risk factors, business overview, management, financial data, and other disclosures typical of an IPO prospectus. This is not an annual report, earnings release, or any other financial report but a registration statement for a capital raising event. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). Since this is a registration statement for an IPO, it is best classified as a Capital/Financing Update (CAP).
2019-07-27 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter from legal counsel submitting a draft Registration Statement on Form S-1 confidentially to the SEC for non-public review. It is not the Registration Statement itself, nor does it contain financial data or report content. It is a regulatory filing related to the registration process for securities but does not fit into categories like Annual Report, Earnings Release, or Capital Update. Given the nature as a confidential submission letter to the SEC, it best fits under Regulatory Filings (RNS). The document length is short and it is a letter, not a report or announcement of voting results or management changes.
2019-07-27 English
Regulatory Filings 2019
Regulatory Filings
2019-03-26 English
Regulatory Filings 2019
Regulatory Filings
2019-03-26 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.